Endologix, Inc. (ELGX) - Product Pipeline Analysis, 2014 Update - New Market Study Published

Boston, MA -- (SBWIRE) -- 07/24/2014 -- Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). Its products are built on one of the two platforms, namely, traditional minimally-invasive endovascular repair (EVAR) or endovascular sealing (EVAS). The company's EVAR products include AFX Endovascular AAA System and Intuitrak Endovascular AAA System; and EVAS products comprise Nellix Endovascular Aneurysm Sealing System. The company sells its ELG system to hospitals in the US, Europe, and to third-party international distributors. It has manufacturing facility in Irvine. Endologix is headquartered in California, the US.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.